In the BioHarmony Drug Report Database

"Preview" Icon

Nafamostat mesylate

Nafamostat mesylate is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target complement C1r subcomponent, trypsin-1, acid-sensing ion channel 1, acid-sensing ion channel 2, acid-sensing ion channel 3, transient receptor potential cation channel subfamily M member 7, and tryptase alpha/beta-1.


Trade Name



Common Name


nafamostat mesylate







Drug Class


Enzyme inhibitors: proteolytic enzyme inhibitors

Image (chem structure or protein)

Nafamostat mesylate structure rendering